EcoDrugPlus

Tubulin Beta 2b Class Iib

Ensembl ID : ENSMLUG00000006805
Gene Symbol: TUBB2B
2 Cross references
178 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSMLUG00000000989
Gene Symbol: TUBB3
1 Cross references
143 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSMLUG00000015607
Gene Symbol: TUBB4A
2 Cross references
94 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSMLUG00000016219
Gene Symbol: TUBB6
2 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSMLUG00000006286
Gene Symbol: TUBB
2 Cross references
262 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMLUG00000016206
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMLUG00000012345
Gene Symbol: TYK2
2 Cross references
196 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSMLUG00000012578
Gene Symbol: TIE1
4 Cross references
203 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSMLUG00000001109
Gene Symbol: UTS2R
2 Cross references
102 Possible Orthologues:

Utrophin

Ensembl ID : ENSMLUG00000009057
Gene Symbol: UTRN
2 Cross references
251 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSMLUG00000014519
Gene Symbol: VEGFA
2 Cross references
253 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSMLUG00000000912
Gene Symbol: VDR
2 Cross references
458 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).